Systemic Lupus Erythematosus

<p>Pathology of Systemic Lupus Erythematosus - The Challenges Ahead.- The Lupus Biomarker Odyssey: One Experience.- Detection of Anti Nuclear Antibodies in SLE.- Tests for Circulating Immune Complexes.- Methods for Measuring Antibody Dependent Cell-Mediated Cytotoxicity in vitro.- Recombinant Antibody Microarray for Profiling the Serum Proteome of SLE.- Bi-functional Antibody Fragment-based Fusion Proteins for the Targeted Elimination of Pathogenic T-cell Subsets.- TLC Immunostaining for Detection of “Anti-Phospholipid” Antibodies.- Induced Murine Models of Systemic Lupus Erythematosus.- Measuring Interferon Alpha and other Cytokines in SLE.- Detection of SLE antigens in Neutrophils Extracellular Traps (NETs).- Detection and Characterization of Autoantibodies Against Modified Self-proteins in SLE Sera after Exposure to Reactive Oxygen and Nitrogen Species.- Generation of Self-peptides to Treat Systemic Lupus Erythematosus.- Measurement of Malondialdehyde, Glutathione and Glutathione Peroxidase in SLE Patients.- Evaluating a Particular Circulating MicroRNA Species from an SLE Patient using Stem Loop qRT-PCR.- Microarray Technology for Analysis of MicroRNA Expression in Renal Biopsies of Lupus Nephritis Patients. Laboratory Tests for the Antiphospholipid Syndrome.- Isolation, Polarisation and Expansion of CD4⁺ T Helper Cell Lines and Clones using Magnetic Beads.- Meta-analysis as a Diagnostic Tool for Predicting Disease Onset and/or Activity in Systemic Lupus Erythematosus.</p>